Ocular Myasthenia Gravis-This occurs when the disease-related muscle weakness is restricted to the muscles of the eyes. Transient neonatal Myasthenia Gravis-This form of the disease mainly occurs ...
Namibian Sun on MSN7 个月
How common is myasthenia gravis?
This is the most common type. • Neonatal myasthenia: A fetus gets certain antibodies from the birthing parent who has myasthenia gravis. An infant may have a weak cry or sucking reflex at birth.
MedPage Today on MSN4 天
Myasthenia Gravis Exacerbations
Generalized myasthenia gravis (gMG) affects most patients through a handful of well-characterized neuromuscular junction ...
For this study, outcomes were compared between 2 groups of patients with myasthenia gravis: those who developed exacerbations and those who did not experience exacerbations. A new report offers ...
Opens in a new tab or window Recently approved treatments for generalized myasthenia gravis (gMG), including complement and neonatal Fc receptor (FcRn) inhibitors, offer a new treatment paradigm ...
This effect may explain in part the variability in the development of neonatal myasthenia gravis in the babies, due to transplacental transfer of maternal anti-AcChoR antibody, only after delivery ...
Vyvgart attaches to a part of these antibodies, called neonatal Fc receptors (FcRn ... the effect of Vyvgart using a test called the Myasthenia Gravis-Specific Activities of Daily Living scale ...
Sanofi's decision to end development of the drug in myasthenia gravis may lie in the changing landscape of therapies for the disease, including the approval of Argenx' neonatal FC receptor (FcRn ...
Argenx only recently scored FDA approval for its intravenous anti-neonatal FC receptor (FcRn) antibody Vyvgart for generalised myasthenia gravis (gMG), but is already looking to defend its ...
Decreased AChR-Ab titers correlated with improved myasthenia gravis symptoms, especially in ADL scores, within the first 3 months of treatment. The study found no baseline correlation between AChR ...
Welcome, everyone. I'm Dr. John Whyte, the Chief Medical Officer at WebMD. Today, I want to discuss myasthenia gravis. It's a rare autoimmune neuromuscular disease that causes weakness and fatigue ...